Skip to main content
. 2021 May 21;54(1):24–31. doi: 10.1111/apt.16404

TABLE 3.

Incidence of the primary outcome in the ginger and placebo arms

ITT

equal case scenario

ITT

worst‐case scenario

PPA
Placebo event rate placebo

65/75

0.87 [0.79 to 0.94]

61/75

0.81 [0.73 to 0.90]

61/71

0.86 [0.78 to 0.94]

Ginger event rate ginger

50/75

0.67 [0.56 to 0.77]

50/75

0.67 [0.56 to 0.77]

45/70

0.64 [0.53 to 0.76]

Absolute risk reduction (ginger‐placebo)

−0.20 a [−0.33 to −0.07]

P = 0.003 (Wald)

−15 a [−0.29 to −0.006]

P = 0.038 (Wald)

−0.22 a [−0.35 to −0.08]

P = 0.002 (Wald)

Number needed to treat 5 b [3 to 15] 7 b [4 to 167] 5 b [3 to 14]
Number of children 150 150 141

Values are proportions and 95% confidence interval (in square brackets) from binomial regression. The ITT “equal case scenario” analysis assumes the occurrence of the best outcome (no vomiting) in the 5 children lost to follow‐up in the ginger arm and of the same outcome (no vomiting) in the 4 children lost to follow‐up in the placebo arm. The ITT “worst case scenario” analysis assumes the occurrence of the worst outcome (vomiting) in the 5 children lost to follow‐up in the ginger arm and of the best outcome (no vomiting) in the 4 children lost to follow‐up in the placebo arm.

Abbreviations: ITT, intention‐to treat analysis; PPA, per‐protocol analysis.

a

95 confidence interval calculated from binomial regression.

b

95 confidence interval calculated from Bender's formula.